142 related articles for article (PubMed ID: 38460151)
1. Multidisciplinary Approach for the Management of Metastatic Poorly Differentiated Neuroendocrine Carcinoma of the Pancreas: A Case Report of an Exceptional Responder.
Nakasone ES; Bustillos HC; Gui X; Konnick EQ; Sham JG; Cohen SA
Pancreas; 2024 Jul; 53(6):e487-e491. PubMed ID: 38460151
[TBL] [Abstract][Full Text] [Related]
2. Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice.
Bruera G; Giuliani A; Romano L; Chiominto A; Di Sibio A; Mastropietro S; Cosenza P; Ricevuto E; Schietroma M; Carlei F;
BMC Cancer; 2019 Oct; 19(1):960. PubMed ID: 31619203
[TBL] [Abstract][Full Text] [Related]
3. [A successful two-stage treatment with CDDP and CPT-11 for pancreatic neuroendocrine carcinoma with liver metastasis].
Nomura S; Togawa A; Kaiho T; Shinmura K; Yanagisawa S; Okamoto R; Nishimura M; Tsuchiya S; Miyazaki M
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1897-900. PubMed ID: 19920396
[TBL] [Abstract][Full Text] [Related]
4. Poorly differentiated neuroendocrine carcinoma of the pancreas responsive to combination therapy with gemcitabine and S-1.
Yamamoto M; Miyagawa K; Hiura M; Taguchi M; Kihara Y; Abe S; Shimajiri S; Harada M
Intern Med; 2012; 51(7):727-32. PubMed ID: 22466828
[TBL] [Abstract][Full Text] [Related]
5. Long Survival and Prolonged Remission after Surgery and Chemotherapy in a Metastatic Mismatch Repair Deficient Pancreatic Neuroendocrine Carcinoma with MLH1/PMS2 Immunodeficiency and Minimal Microsatellite Shift.
Vanoli A; Perfetti V; Furlan D; Neri G; Viglio A; Sessa F; Martino M; Di Sabatino A; Solcia E; La Rosa S
Endocr Pathol; 2020 Dec; 31(4):411-417. PubMed ID: 32388775
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
[TBL] [Abstract][Full Text] [Related]
7. Curative surgery after neoadjuvant chemotherapy in metastatic poorly differentiated neuroendocrine carcinoma.
Sørbye H; Westre B; Horn A
Eur J Surg Oncol; 2007 Dec; 33(10):1209-10. PubMed ID: 17350785
[No Abstract] [Full Text] [Related]
8. The prognostic influence of the proliferative discordance in metastatic pancreatic neuroendocrine carcinoma revealed by peptide receptor radionuclide therapy: Case report and review of literature.
Montanier N; Joubert-Zakeyh J; Pétorin C; Montoriol PF; Maqdasy S; Kelly A
Medicine (Baltimore); 2017 Feb; 96(6):e6062. PubMed ID: 28178157
[TBL] [Abstract][Full Text] [Related]
9. Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology.
Crippa S; Partelli S; Belfiori G; Palucci M; Muffatti F; Adamenko O; Cardinali L; Doglioni C; Zamboni G; Falconi M
World J Gastroenterol; 2016 Dec; 22(45):9944-9953. PubMed ID: 28018101
[TBL] [Abstract][Full Text] [Related]
10. [A case of multiple liver metastases from nonfunctioning neuroendocrine pancreatic tumor curatively resected after successful intra-arterial chemotherapy].
Kametaka H; Makino H; Koyama T; Seike K; Hasegawa A
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2367-9. PubMed ID: 21224575
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival following hepatectomy, radiation, and chemotherapy for recurrent pancreatic carcinoma: a case report.
Fujisaki S; Takashina M; Tomita R; Sakurai K; Takayama T
World J Surg Oncol; 2017 Aug; 15(1):157. PubMed ID: 28835248
[TBL] [Abstract][Full Text] [Related]
12. Long-term control with chemoradiation of initially metastatic mixed adenoneuroendocrine carcinoma of the rectum: a case report.
Semrau S; Agaimy A; Pavel M; Lubgan D; Schmidt D; Cavallaro A; Golcher H; Grützmann R; Fietkau R
J Med Case Rep; 2019 Mar; 13(1):82. PubMed ID: 30902067
[TBL] [Abstract][Full Text] [Related]
13. Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.
Galleberg RB; Knigge U; Tiensuu Janson E; Vestermark LW; Haugvik SP; Ladekarl M; Langer SW; Grønbæk H; Österlund P; Hjortland GO; Assmus J; Tang L; Perren A; Sorbye H
Eur J Surg Oncol; 2017 Sep; 43(9):1682-1689. PubMed ID: 28522174
[TBL] [Abstract][Full Text] [Related]
14. [Poorly differentiated endocrine carcinoma of the colon].
Saint-Blancard P; Hervouet M; Chapuis O
Rev Med Interne; 2010 Jun; 31(6):e10-2. PubMed ID: 20167397
[TBL] [Abstract][Full Text] [Related]
15. Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.
Basturk O; Tang L; Hruban RH; Adsay V; Yang Z; Krasinskas AM; Vakiani E; La Rosa S; Jang KT; Frankel WL; Liu X; Zhang L; Giordano TJ; Bellizzi AM; Chen JH; Shi C; Allen P; Reidy DL; Wolfgang CL; Saka B; Rezaee N; Deshpande V; Klimstra DS
Am J Surg Pathol; 2014 Apr; 38(4):437-47. PubMed ID: 24503751
[TBL] [Abstract][Full Text] [Related]
16. Metastasized pancreatic carcinoma with neoadjuvant FOLFIRINOX therapy and R0 resection.
Schneitler S; Kröpil P; Riemer J; Antoch G; Knoefel WT; Häussinger D; Graf D
World J Gastroenterol; 2015 May; 21(20):6384-90. PubMed ID: 26034375
[TBL] [Abstract][Full Text] [Related]
17. [Small cell neuroendocrine carcinoma of the bladder: A case report and review of the literature].
Chekrine T; De Bari B; Cassier P; Kulisa M; Chapet O; Mornex F
Cancer Radiother; 2011 Jun; 15(3):250-3. PubMed ID: 21420344
[TBL] [Abstract][Full Text] [Related]
18. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.
Feng T; Lv W; Yuan M; Shi Z; Zhong H; Ling S
World J Surg Oncol; 2019 Mar; 17(1):54. PubMed ID: 30898132
[TBL] [Abstract][Full Text] [Related]
19. [A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy].
Hoshino H; Takeda Y; Nagano H; Nakamori S; Kobayashi S; Eguchi H; Marubashi S; Tanemura M; Kitagawa T; Umeshita K; Monden M; Doki Y; Mori M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2419-21. PubMed ID: 20037442
[TBL] [Abstract][Full Text] [Related]
20. A large cell neuroendocrine carcinoma of the gall bladder: diagnosis with 18FDG-PET/CT-guided biliary cytology and treatment with combined chemotherapy achieved a long-term stable condition.
Okuyama Y; Fukui A; Enoki Y; Morishita H; Yoshida N; Fujimoto S
Jpn J Clin Oncol; 2013 May; 43(5):571-4. PubMed ID: 23532186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
